Neurological pathogenesis of SARS-CoV-2 (COVID-19): from virological features to clinical symptoms
Y Kase, H Okano - Inflammation and regeneration, 2021 - Springer
Since the worldwide outbreak of coronavirus disease 2019 (COVID-19) in 2020, various
research reports and case reports have been published. It has been found that COVID-19 …
research reports and case reports have been published. It has been found that COVID-19 …
Chronic long‐COVID syndrome: A protracted COVID‐19 illness with neurological dysfunctions
AM Baig - CNS Neuroscience & Therapeutics, 2021 - Wiley Online Library
After almost a year of COVID‐19, the chronic long‐COVID syndrome has been recognized
as an entity in 2021. The patients with the long‐COVID are presenting with ominous …
as an entity in 2021. The patients with the long‐COVID are presenting with ominous …
COVID-19 causes neuronal degeneration and reduces neurogenesis in human hippocampus
AH Bayat, H Azimi, M Hassani Moghaddam… - Apoptosis, 2022 - Springer
Recent investigations of COVID-19 have largely focused on the effects of this novel virus on
the vital organs in order to efficiently assist individuals who have recovered from the …
the vital organs in order to efficiently assist individuals who have recovered from the …
Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19
A spectrum of neurological disease associated with COVID-19 is becoming increasingly
apparent. However, the mechanisms behind these manifestations remain poorly …
apparent. However, the mechanisms behind these manifestations remain poorly …
Pathological features and neuroinflammatory mechanisms of SARS-CoV-2 in the brain and potential therapeutic approaches
The number of deaths has been increased due to COVID-19 infections and uncertain
neurological complications associated with the central nervous system. Post-infections and …
neurological complications associated with the central nervous system. Post-infections and …
A comprehensive review of neurodegenerative manifestations of SARS-CoV-2
The World Health Organization reports that severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has impacted a staggering 770 million individuals to date. Despite the …
(SARS-CoV-2) has impacted a staggering 770 million individuals to date. Despite the …
Emerging neurological and psychobiological aspects of COVID-19 infection
L Tancheva, MC Petralia, S Miteva, S Dragomanova… - Brain sciences, 2020 - mdpi.com
The SARS-CoV-2 virus, first reported in December 2019 in China, is the causative agent of
the current COVID-19 pandemic that, at the time of writing (1 November 2020) has infected …
the current COVID-19 pandemic that, at the time of writing (1 November 2020) has infected …
Neuropathogenesis of acute coronavirus disease 2019
SF Farhadian, D Seilhean… - Current Opinion in …, 2021 - journals.lww.com
Neuroimmune perturbations and vascular inflammation observed in people with COVID-19
may warrant investigation of immune-modulating interventions to ameliorate neurological …
may warrant investigation of immune-modulating interventions to ameliorate neurological …
Long COVID, the brain, nerves, and cognitive function
AB Reiss, C Greene, C Dayaramani… - Neurology …, 2023 - mdpi.com
SARS-CoV-2, a single-stranded RNA coronavirus, causes an illness known as coronavirus
disease 2019 (COVID-19). Long-term complications are an increasing issue in patients who …
disease 2019 (COVID-19). Long-term complications are an increasing issue in patients who …
Neuropathobiology of COVID-19: the role for glia
ME Tremblay, C Madore, M Bordeleau… - Frontiers in cellular …, 2020 - frontiersin.org
SARS-CoV-2, which causes the Coronavirus Disease 2019 (COVID-19) pandemic, has a
brain neurotropism through binding to the receptor angiotensin-converting enzyme 2 …
brain neurotropism through binding to the receptor angiotensin-converting enzyme 2 …